A multicentre clinical study of nimesulide in inflammatory diseases of the ear, nose and throat.
940 male and female patients aged 15 to 77 years were enrolled in a multicentre noncomparative study in order to assess the efficacy and tolerability of nimesulide in otorhinolaryngological inflammatory diseases. 309 patients were affected by otitis media and 631 by upper respiratory tract inflammation. All the patients were treated with orally administered granular nimesulide 100mg twice daily for a mean period of 10 days. Nimesulide significantly reduced the intensity of signs and symptoms, thus allowing functional recovery. The drug was well tolerated, and of the 75 patients who reported adverse effects, only 26 had to be withdrawn from treatment.
Ottaviani
A
A
Clinica Otorinolaringoiatrica, Università di Milano, Italy.
Mantovani
M
M
Scaricabarozzi
I
I
D000293:Adolescent; D000328:Adult; D000368:Aged; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007827:Laryngitis / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D010033:Otitis Media / Q000188:drug therapy*; D010612:Pharyngitis / Q000188:drug therapy*; D013449:Sulfonamides / Q000627:therapeutic use*; D014069:Tonsillitis / Q000188:drug therapy*
D000894:Anti-Inflammatory Agents, Non-Steroidal; D013449:Sulfonamides; C012655:nimesulide